Endologix Announces FDA Approval of AFX Endovascular AAA System

Endologix, Inc.

announced today that it has received U.S. Food and Drug Administration approval for its next generation product, the AFX™ Endovascular AAA System, for the treatment of abdominal aortic aneurysms . Endologix is introducing AFX at the Annual Meeting of the Society for Vascular Surgery, which is taking place June 16-18, 2011 in Chicago, IL.